Nykredit A S Buys Shares of 34,360 The Clorox Company $CLX

Key Points

• Nykredit A/S initiated a position in Clorox by purchasing 34,360 shares valued at approximately $3.28 million. Institutional investors collectively own 78.53% of the company.
• Clorox exceeded quarterly expectations with earnings of $1.66 per share and revenue of $1.95 billion, although revenue declined 2% year over year and prior-year EPS was $2.87.
• Clorox raised its quarterly dividend to $1.25, equivalent to a 5.4% annualized yield, but analysts remain cautious with a consensus “Reduce” rating and an average price target of $102.40.

Nykredit A S bought a new position in The Clorox Company (NYSE:CLX - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 34,360 shares of the company's stock, valued at approximately $3,279,000.

Other hedge funds have also recently modified their holdings of the company. Caitlin John LLC increased its holdings in Clorox by 1,807.1% in the 4th quarter. Caitlin John LLC now owns 267 shares of the company's stock worth $27,000 after buying an additional 253 shares in the last quarter. Ancora Advisors LLC bought a new position in Clorox during the 2nd quarter valued at about $28,000. Avalon Trust Co purchased a new stake in shares of Clorox during the 2nd quarter valued at about $29,000. Darwin Wealth Management LLC purchased a new stake in shares of Clorox during the 2nd quarter valued at about $29,000. Finally, Root Financial Partners LLC grew its stake in shares of Clorox by 83.8% in the first quarter. Root Financial Partners LLC now owns 318 shares of the company's stock worth $33,000 after acquiring an additional 145 shares during the period. Hedge funds and other institutional investors own 78.53% of the company's stock.

Clorox Stock Down 0.0%

Shares of CLX stock opened at $93.05 on Monday. The company has a debt-to-equity ratio of 15.80, a current ratio of 0.66 and a quick ratio of 0.38. The Clorox Company has a one year low of $84.70 and a one year high of $128.90. The company's fifty day moving average price is $99.89 and its 200-day moving average price is $101.55. The company has a market capitalization of $11.25 billion, a price-to-earnings ratio of 19.30, a PEG ratio of 2.91 and a beta of 0.56.

Clorox (NYSE:CLX - Get Free Report) last issued its earnings results on Monday, August 3rd. The company reported $1.66 earnings per share for the quarter, topping the consensus estimate of $1.64 by $0.02. Clorox had a net margin of 8.74% and a return on equity of 522.23%. The company had revenue of $1.95 billion during the quarter, compared to the consensus estimate of $1.91 billion. During the same quarter in the prior year, the firm posted $2.87 EPS. Clorox's quarterly revenue was down 2.0% compared to the same quarter last year. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. Sell-side analysts expect that The Clorox Company will post 5.8 EPS for the current fiscal year.

Clorox Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 28th. Stockholders of record on Wednesday, August 12th were paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 5.4%. This is a positive change from Clorox's previous quarterly dividend of $1.24. The ex-dividend date of this dividend was Wednesday, August 12th. Clorox's dividend payout ratio is currently 103.73%.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on CLX shares. UBS Group increased their price objective on shares of Clorox from $100.00 to $105.00 and gave the company a "neutral" rating in a research report on Tuesday, August 4th. Zacks Research downgraded shares of Clorox from a "hold" rating to a "strong sell" rating in a research report on Tuesday, May 12th. Wall Street Zen lowered shares of Clorox from a "hold" rating to a "sell" rating in a research note on Saturday, August 15th. Citigroup increased their price target on Clorox from $97.00 to $100.00 and gave the company a "neutral" rating in a report on Tuesday, August 4th. Finally, BNP Paribas Exane dropped their price target on Clorox from $97.00 to $95.00 and set a "neutral" rating on the stock in a research note on Monday, July 20th. Twelve research analysts have rated the stock with a Hold rating and five have issued a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Reduce" and an average price target of $102.40.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company's flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox's diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source